{
  "pmid": "30262580",
  "uid": "30262580",
  "title": "Higher-risk APS: do we dare to DOAC?",
  "abstract": "",
  "authors": [
    {
      "last_name": "Laureano",
      "fore_name": "Marissa",
      "initials": "M",
      "name": "Marissa Laureano",
      "affiliations": [
        "McMaster University."
      ]
    },
    {
      "last_name": "Crowther",
      "fore_name": "Mark A",
      "initials": "MA",
      "name": "Mark A Crowther",
      "affiliations": [
        "McMaster University."
      ]
    }
  ],
  "journal": {
    "title": "Blood",
    "iso_abbreviation": "Blood",
    "issn": "1528-0020",
    "issn_type": "Electronic",
    "volume": "132",
    "issue": "13",
    "pub_year": "2018",
    "pub_month": "Sep",
    "pub_day": "27"
  },
  "start_page": "1357",
  "end_page": "1358",
  "pages": "1357-1358",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Comment"
  ],
  "keywords": [
    "Anticoagulants",
    "Antiphospholipid Syndrome",
    "Humans",
    "Rivaroxaban",
    "Stroke",
    "Warfarin"
  ],
  "article_ids": {
    "pubmed": "30262580",
    "doi": "10.1182/blood-2018-08-867036",
    "pii": "S0006-4971(20)60715-7"
  },
  "doi": "10.1182/blood-2018-08-867036",
  "dates": {
    "completed": "2019-07-08",
    "revised": "2021-02-02"
  },
  "chemicals": [
    "Anticoagulants",
    "Warfarin",
    "Rivaroxaban"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:16:41.688430",
    "pmid": "30262580"
  }
}